responsiveness with in vitro cystathionine /8-synthase activity in extracts of confluent fibroblasts from 14 synthase-deficient patients. Enzyme activity was measured with and without addition of its cofactor, pyridoxal-5'-phosphate, using a radioisotopic assay which detects as little as 0.25% of control activity. Six of seven lines from responsive patients had measurable activity without the added cofactor (0.6-15% of mean control). Two of these lines showed a five-and sevenfold stimulation of cystathionine ,B-synthase activity with added pyridoxal-5'-phosphate; in the other four, the cofactor addition increased activity only modestly, as in controls. Two of seven lines from nonresponsive patients had measurable activity (each 3% of mean control) which increased two-and fivefold with the added cofactor. Cystathionine ,8-synthase activity was undetectable in one line from a responsive patient and in five lines from nonresponsive ones. To characterize control and mutant synthase further, dissociation constants for pyridoxal-5'-phosphate were estimated and thermostability (54°C) was studied in two control and five mutant lines. In one mutant, both parameters were normal; in the others, the affinity for the cofactor was reduced 3-to 11-fold and thermostability was much impaired. We conclude that at least three general classes of cystathionine 83-synthase mutants exist: those with no residual activity; those with reduced activity and normal affinity for pyridoxal-5'phosphate; and those with reduced activity and a reduced affinity for the cofactor. Pyridoxine responsiveness in vivo cannot be correlated simply with the presence or absence of residual synthase activDr.
A B S T R A C T We have compared in vivo pyridoxine
responsiveness with in vitro cystathionine /8-synthase activity in extracts of confluent fibroblasts from 14 synthase-deficient patients. Enzyme activity was measured with and without addition of its cofactor, pyridoxal-5'-phosphate, using a radioisotopic assay which detects as little as 0.25% of control activity. Six of seven lines from responsive patients had measurable activity without the added cofactor (0.6-15% of mean control). Two of these lines showed a five-and sevenfold stimulation of cystathionine ,B-synthase activity with added pyridoxal-5'-phosphate; in the other four, the cofactor addition increased activity only modestly, as in controls. Two of seven lines from nonresponsive patients had measurable activity (each 3% of mean control) which increased two-and fivefold with the added cofactor. Cystathionine ,8-synthase activity was undetectable in one line from a responsive patient and in five lines from nonresponsive ones. To characterize control and mutant synthase further, dissociation constants for pyridoxal-5'-phosphate were estimated and thermostability (54°C) was studied in two control and five mutant lines. In one mutant, both parameters were normal; in the others, the affinity for the cofactor was reduced 3-to 11-fold and thermostability was much impaired. We conclude that at least three general classes of cystathionine 83-synthase mutants exist: those with no residual activity; those with reduced activity and normal affinity for pyridoxal-5'phosphate; and those with reduced activity and a reduced affinity for the cofactor. Pyridoxine responsiveness in vivo cannot be correlated simply with the presence or absence of residual synthase activ-
INTRODUCTION
The most common type of inherited homocystinuria is characterized clinically by dislocated lenses, skeletal abnormalities, intravascular thromboses, and mental retardation, and chemically by increased concentrations of homocystine and methionine in plasma and turine (1, 2) . A marked deficiency of cystathionine /3-synthase (CS)' activity has been demonstrated in the liver (3), brain (4), cultuired skin fibroblasts (5) and phytohemagglutinin-stimulated lymphocytes (6) (7) (8) (9) and catalyzes the condensation of serine and homocysteine to form cystathionine.
Approximately half of the reported patients with CS deficiency show a return of plasma and urine methionine and homocystine concentrations to normal or near normal values in response to treatment with pharnmacologic amounts of pyridoxine, the vitamin precursor of PLP (10, 11) . Several investigators have attempted to define the biochemical mechanism of this respoinse. In some responsive patients, the addition of PLP to crude liver and cultured fibroblast homogenates vas showni to result in either slight or significant increases in the activity of CS, whereas in other responsive patients, no stimulation of residual activity was observed (12) (13) (14) (16) reached different conclusions from studies of PLP kinetics and thermostability on partially purified CS from three other pyridoxine-responsive patients. They found that the muitant enzymes exhibited a reduced affinity for PLP and a decreased thermostability. They proposed that, in the presence of physiologic amounts of PLP, little holo-CS exists and apo-CS turnover is accelerated; and that, when tissue PLP content rises in response to pyridoxine supplements, holo-CS content is increased and apo-CS turnover is decreased. As a result, catalytic activity is enhanced.
In the present study, CS activity was measured in cultured fibroblast extracts from 14 homocystinuric patients with defined responses to pyridoxine treatment. The results suggest an initial classification of CS mutants based on residual activity, affinity of aposynthase for cofactor, and thermostability. The extent to which in vivo pyridoxine responsiveness can be correlated with these in vitro properties of CS is reexamined. lowed by dialysis against two changes of the same buffer without hyrdroxylamine. In all but one of the five mutant lines tested (no. 4), CS was denatured irreversibly by this treatment. In three of these mutant lines (nios. 2, 5, 14) , we used dialvsis for 6 and 18 h in hydroxylamine-containing and hydroxylamine-free buffers, respectively. In the fourth (no. 13 CS activity in crude extracts of culturedfibroblasts. CS activity in six control lines (Fig. 2) assayed without added PLP ranged from 2.7 to 7.8 U (mean 5.3) and increased modestly when PLP (1 mM) was added to the assay mix (range 3.4-10.5, mean 6.8 U). CS activities in cell lines from patients with homocystinuria are Table I. shown in Fig. 3 . In the absence of added PLP, six out of seven lines from in vivo pyridoxine responsive patients and two out of seven lines from in vivo nonresponsive ones have clearly measurable synthase activity (0.6-15 and 3.0-3.3% of mean control values, respectively). CS activity was undetectable in one line from an in vivo pyridoxine-responsive patient and in five lines from nonresponsive ones. Of the lines from responsive patients, two (nos. 2 and 5) showed a large stimulation (five-and sevenfold) of synthase activity when PLP was added in vitro, whereas four showed only modest increases similar to those observed in controls. The lines from nonresponsive patients with detectable synthase activity (nos. 13 and 14) showed twoto fivefold increases in CS activity with added PLP. One exceptional line from an in vivo nonresponsive patient (no. 10) had no activity in the absence of added PLP but 1.1% of control activity when the coenzyme was added.
METHODS
The in vitro stimulation of CS activity by the addition of PLP may be summarized as follows. There are three types of response: first, a modest increase observed in all the control lines (21-33%) and in four lines from in vivo pyridoxine-responsive patients (25-46%) Effect of storage cotnditions on CS activity. The above described results were obtained with fibroblast extracts prepared from cell pellets frozen at -70°C. As noted in Fig. 4 , however, storage conditions had an appreciable effect on CS activity. Whereas activity was the same in freshly prepared extracts as in extracts from cells frozen at -70°C, storage of extracts at 4°C or dialysis at 4°C against the extraction buffer resulted in marked increases in CS activity (37 and 113% greater than freshly prepared extracts, respectively). Such stimulation was observed in the absence and presence of added PLP, and was noted in all control and mutant extracts ,exposed to these conditions.
Resolution of control and mutant holo-CS. CS activity was further examined in apo-CS preparations from two control and from the five mutant lines with the 45 EJ-PLP greatest residual total enzyme activity. The relative amounts of apo-CS are expressed as a percentage of the total CS ofthe same preparation assayed with saturating amouints of PLP. Hydroxylamine treatment of extracts from the two controls and mutant 4 resolved nearly all holo-CS to apo-CS, the latter accounting for 93-95% of total CS in the treated extracts compared to 15-35% in the untreated ones. In each of the four other mutant lines studied, apo-CS accounted for a much larger fraction of total CS in the untreated extracts (80% in mutant 2; 76% in mutant 5; 70% in mutant 13; and 50% in mutant 14). The modified resolution conditions employed with these lines (MIethods) yielded the following fractional apo-CS values: 98% in mutant 2; 85% in mutant 5; 70% in mutant 13; and 79% in mutant 14. Affility of control atnd mutant CS for PLP. CS activity in the absence of added PLP and in the presence of increasing amounts of coenzyme was determined using the apo-CS preparations just described. For each preparation tested, typical Michaelis-Menton kinetics were observed as PLP concentrations were increased (Fig. 5) . The maximal velocity observed for each mutant line was much less than that in controls, even at saturating concentrations of PLP. The affinity for PLP of CS apoenzyme from mutants 2 and 13 (similar findings were observed for mutants 5 and 14 whose data is not shown) was distinctly reduced when compared to that observed for apoenzyme from controls and mutant 4. Estimated cofactor dissociation constants (Kd PLP) for the two control and five mutant lines tested were calculated from Hill plots (Fig. 6) . The Kd PLP for CS from mutant 4 (22 uM) was very similar to that for controls (23 and 30 A.tM) whereas the Kd PLP for each ofthe other mutant lines ranged from 2-to 11-fold higher.
Thermostability of control and mutant CS. The data in Fig. 7 show the effect of heat (at 54°C) on total synthase activity in an apoenzyme preparation from control fibroblasts and in its holoenzyme counterpart preparation by addition of PLP (2 mM) before heating. Both preparations showed an initial increase of CS activity during heating, this effect was more prominent for the holoenzyme. Thereafter, there was no appreciable loss of activity over the 45-min interval for the holo-CS whereas the apo-CS showed a steady loss of activity, with only 20% of the initial activity remaining after 45 min. Other experiments (Fig. 8) indicate that mutant apo-CS is more thermolabile than control apo-CS. Once again, thermostability at 54°C was determined in extracts of control and mutant fibroblasts. No attempt was made to resolve PLP from these preparations and PLP was not added before heating. There are clear differences between controls and mutants, the former again showing an initial increase in CS activity followed by a steady loss reminiscent of the plot for apo-CS in Fig. 7 . In contrast, mutants 2, 5, 13, and 14 (previously demonstrated to have a much greater fracThree Classes of Cystathionine /3-Synthase MutantsCONTROLS mutant lines was very reduced when compared to the control values, but varied considerably within the mutant group from nondetectable to 18% of the control values. Second, examination of residual CS activity found in the absence of added PLP confirms (15) a general difference between the in vivo responsive and nonresponsive patients. Cells from all but one of the responsive patients had measurable activity, ranging from 0.6 to 15% of mean control values. In contrast, cells from five of seven nonresponsive patients had no detectable residual synthase activity. However, as in the study of Uhlendorf et al. (15) , there are exceptions to the thesis that in vivo pyridoxine responsiveness can be simply correlated with the presence of residual MUTANTS synthase activity in cultured cells. Cells from one responsive patient (mutant 6) had no residual activity even when 0.7 mg of protein was included in the assay, and cells from two nonresponsive patients (mutants 3 13 and 14) contained measurable activity in all batches of cells studied. Third, four of the mutant cell lines n 2 (two from responsive and two from nonresponsive patients) contained synthase activity which showed in-1000 r FIGuRE 5 The effect of increasing PLP concentration on CS activity in cultured fibroblast extracts from control (A) and mutant lines (B) . For controls and mutant 4, CS apoenzyme was prepared by dialysis ofthe extract in 1 mM hydroxylamine in 0.05 M potassium phosphate buffer, pH 7.5 for 24 h followed by dialysis in the same buffer without hydroxylamine for 24 h. For preparation of apoenzyme from mutant 2, dialysis was used for 6 and 18 h in 1 mM hydroxylamine and buffer, respectively. For mutant 13 the extract was dialyzed in buffer without hydroxylamine for 2 h. Before assay, extracts were preincubated with varying concentrations of PLP for 60 min at 37°C. The scale of the ordinate of B is 1/10th that of A. tion of their total CS content in the apoenzyme form) showed no initial stimulation and a much more rapid decay of CS activity than did controls. Mutant 4 (whose apo-CS fraction and Kd PLP are similar to controls) showed an initial rise in activity with subsequent decay to intermediate values between those of the controls and other mutants.
DISCUSSION
A sensitive assay for CS activity in extracts of cultured skin fibroblasts from patients with CS deficiency has been used to determine whether in vivo pyridoxine responsiveness can be correlated with in vitro properties of the enzyme. The patients were well characterized, in terms of clinical severity and the effect of pharmacological doses of pyridoxine on plasma and urine concentrations of amino acids. The following findings deserve mention. First, the specific activity of CS in the Estimation from Hill plots of PLP dissociation constants (Kd PLP) for control ( ) and mutant (in vivo pyridoxine-responsive ---; in vivo pyridoxine nonresponsive * * ) CS. Extracts of cultured skin fibroblasts of control 1 (V) and 5 (A) and mutants 2 (O) 4 (0) and 13 (0) were prepared as described in the legend to Fig. 5 . Extracts of mutants 5 (A) and 14 (-) were prepared by dialysis in 1 mM hydroxylamine for 6 h followed by dialysis in the buffer without hydroxylamine for 18 h. V = velocity at designated PLP concentration; Vmax = velocity at highest PLP concentration employed; V0 = velocity with no PLP added. Kd PLP was obtained from that concentration of PLP at which V = Vmax/2, i.e., where (V-Vo)/(Vmax-V) = 1.
650
B. Fowler, J. Kraus, S. Packman, and L. E. Rosenberg (12, 16) . In all such previous studies, however, einzyme preparations contained an appreciable fraction of holo-CS. We prepared apo-CS from control and mutant lines to assess this property more rigorously. As reviewed by Snell (19) , widely different conditioins have been employed to resolve PLP-requiring enzymes. Extensive attempts at resolution and reconstitution of control CS holoenzvme yielded conditions which gave maximal Under these conditions, however, CS preparations from mutant lines (apart from mutant 4) showed irre- WVe2 and others (18) Thermostability studies of control apo-and holo-CS and of mutant CS provided two interesting findings. First, control apoenzyme exhibited less thermal activation and greater thermolability than did holo-CS. This stabilization of CS by PLP confirms previous observations with crude extracts of hunman liver (20) and partially purified enzyme from cultured fibroblasts (16) , all of which demonstrate that CS behaves in a manner similar to other PLP enzymes (21-25) which can be stabilized in vivo anid in vitro by pyridoxine administration or PLP addition. Second, using extracts of mutant and control fibroblasts from which bound PLP was not resolved, the control CS was significantly more thermostable than the mutaint enzymes tested. The mutant with a normal Kd PLP exhibited a degree of initial activation and subsequenit decay on an intermediate level found between that of control preparations and the other mutants tested. Thus, it appears that those mutants with a much reduced affinity for PLP, and which therefore exist mainly in the apoenzyme form, tend to be the least stable in regard to heating. It is not possible to be certain that this in vitro thermolability reflects a greater degree of intracellular lability in vivo.
It seems likely that in vivo pyridoxine responsiveness in patients whose CS has a reduced affinity for PLP and(or) reduced stability can be accounted for by a partial, perhaps only modest, enhancement of catalytic activity brought about by the vitamin supplement. Clearly, this construct does not explain responsiveness in patients (no. 4) whose CS exhibits essentially normal kinetics for PLP and near normal stability, or nonresponisiveness in patients (nos. 13 and 14) whose CS properties are still indistinguishable from those fouind in the cells of responsive patients. Other intrinsic properties of CS must be examined to clarify this matter. Tate and Meister (26, 27) showed that catalytic activity of another PLP-dependent enzyme, aspartate ,8-decarboxylase, was modulated by PLP-induced alteration in subunit interaction. Such modulation could play an even more important role in interaction between mutant sul)units. It is, of course, possible that the results of experiments employing cultured cells may not always accurately reflect events in tissues that are more critical in defining the in vivo situation. For instance, variation in any number of steps regulating pyridoxine metabolism-intestinal absorption, binding to plasma proteins, transport into cells, enzymatic conversion to PLP-could account for the failure of patients 13 and 14 to respond to pyridoxine even if their cells contain a mutant enzyme similar or identical to that in cells ofother responsive patients. Furthermore, we cannot dismiss the possibility that pyridoxine responsiveness depends on events other than those directly related to modification of the mutant enzyme. Thus, nonenzymatic complexing of PLP and homocysteine or stimulation of alternate pathways of sulfur amino acid metabolism by PLP could explain some of the changes in plasma or urinary amino acid concentrations observed in responsive patients. No evidence for either mechanism currently exists.
Finally, we conclude that the findings presented in this study indicate the existence of at least three general classes of CS mutants: first, those with no detectable synthase activity; second, those with much reduced activity, normal affinity for PLP and normal heat stability; and third, those with marked reductions in activity, affinity for PLP, and heat stability.
